Skip to main content
Equibles

MORGAN STANLEY

Position in CADL — Candel Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,299,290
+$1,013,970 QoQ
Shares Held
126,145
+116.6% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 138 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. CADL ranks #237 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in CADL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,299,290 126,145
2026-03-31 $285,320 58,229
2025-12-31 $757,273 134,031
2025-09-30 $387,297 75,941
2025-06-30 $575,429 113,722
2025-03-31 $352,987 62,476
2024-12-31 $653,385 75,275
2024-09-30 $446,518 64,433
2024-06-30 $120,639 19,458
2022-12-31 $164 92
2022-09-30 $16,579 5,280
2022-06-30 $14,972 4,621
2022-03-31 $23,673 4,651
2021-12-31 $36,925 4,722